Biotech Curis Announces Closing of Public Offering of Common Stock with $169.6 Million in Gross Proceeds, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares December 14, 2020
Biotech AnPac Bio Makes Significant Progress in Detecting Pre-cancer Diseases and Recorded Over 20 Types of Pre-cancer Diseases December 14, 2020
Biotech Akari Therapeutics Reports Third Quarter 2020 Financial Results and Highlights Recent Clinical Progress December 11, 2020
Biotech Akari Therapeutics Announces New Clinical Data that Show Long-Term Self-Administered Nomacopan is Well-Tolerated and Substantially Reduces Transfusion Dependence in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) December 11, 2020
Biotech Galectin Therapeutics, Inc. to Present at the 4th Annual Digital NASH Summit on December 17, 2020 December 11, 2020
Biotech XOMA Prices $22 Million Offering of Series A Cumulative Perpetual Preferred Stock December 10, 2020
Search
